共聚焦激光显微内镜预测克罗恩病临床结局:一项前瞻性多中心研究结果
这项前瞻性多中心研究纳入49例克罗恩病患者,评估共聚焦激光显微内镜(CLE)对临床结局的预测价值。CLE+组医疗升级和透壁病变发生率更高,基线CRP≥5 mg/L者1年内住院和手术风险增加。CLE可早期预测相关临床结局。
要点
- CLE+组医疗升级风险升高(RR=3.27,P<.001),透壁病变风险升高(RR=1.70,P=.025)。
- 基线CRP≥5 mg/L者1年内克罗恩病相关住院和手术风险升高(RR=2.71,P=.020)。
- CDEIS和CDAI在任何时间点均未发现与预后临床结局的关联。
核心结论
- CLE可显示克罗恩病相关的黏膜炎症特征,并能够早期预测相关临床结局。
- 作者认为后续研究应探讨这一有前景的预后工具能否优化克罗恩病患者治疗策略的时机。
研究设计与样本
- 前瞻性多中心研究,连续纳入接受结肠镜检查的克罗恩病患者49例(53%为男性,中位年龄39岁)。
- 共聚焦成像聚焦于2个高可重复性的活动性结肠炎症组织学标志:局灶性隐窝炎和隐窝结构异常。
- 评估CLE、克罗恩病内镜严重度指数(CDEIS)、血清C反应蛋白(CRP)和克罗恩病活动指数(CDAI)与4年随访期间医疗治疗升级、透壁不良事件及克罗恩病相关住院或手术风险的关联。
主要发现
- 基线CRP≥5 mg/L者占47%,CDEIS≥3者占75%,CDAI>150者占51%。
- 局灶性隐窝炎和隐窝结构异常见于63%的患者(CLE+组)。
- CLE+患者医疗治疗升级发生率增加(P<.001;相对风险[RR]=3.27),透壁病变发生率增加(P=.025;RR=1.70)。
- 基线CRP≥5 mg/L者在1年随访时克罗恩病相关住院和手术增加(P=.020,RR=2.71)。
- 在1年随访期间以及CDEIS和CDAI在任何时间点,均未发现与预后临床结局的进一步关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Assessment of prognostic factors in patients with Crohn's disease (CD) is of pivotal importance for early intervention and "treat-to-target" strategies. Confocal laser endomicroscopy (CLE) enables on-demand in vivo characterization of mucosal inflammatory and architectural changes during endoscopy. We prospectively assessed the value of CLE for prediction of clinical outcome parameters in CD. METHODS: Consecutive patients with CD undergoing colonoscopy were included in a multicenter study. Confocal imaging focused on 2 highly reproducible histologic hallmarks of active colonic inflammation: focal cryptitis and crypt architectural abnormality. We evaluated whether CLE, CD endoscopic index of severity (CDEIS), serum C-reactive protein (CRP), and CD activity index (CDAI) were associated with the risk of medical treatment escalation, transmural adverse events, and CD-related hospitalization or surgery during a 4-year follow-up. RESULTS: Among 49 patients (53% men, median age, 39 years), baseline CRP was ≥5 mg/L in 47%, CDEIS ≥3 in 75%, and CDAI >150 in 51%. Focal cryptitis and crypt architectural abnormality were observed in 63% (CLE+ group). CLE+ patients showed an increased incidence of medical treatment escalation (P < .001; relative risk [RR] = 3.27) and transmural lesions (P = .025; RR = 1.70), whereas patients with CRP ≥5 mg/L had increased CD-related hospitalization and surgery (P = .020, RR = 2.71) at 1-year follow-up. No further association with prognostic clinical outcomes was found over the 1-year follow-up as well as for CDEIS and CDAI at any time. CONCLUSIONS: CLE reveals CD-related features of mucosal inflammation and allows for early prediction of relevant clinical outcomes. Further studies should now address whether this promising prognostic tool could refine the timing of treatment strategies in patients with CD.
引用
- Tontini GE, Mudter J, Vieth M, et al. Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter study. Gastrointest Endosc. 2017. PMID: 29108979. doi:10.1016/j.gie.2017.10.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。